Page last updated: 2024-08-21

psilocybin and Chemical Dependence

psilocybin has been researched along with Chemical Dependence in 109 studies

Research

Studies (109)

Timeframe	Studies, this research(%)	All Research%
pre-1990	41 (37.61)	18.7374
1990's	5 (4.59)	18.2507
2000's	14 (12.84)	29.6817
2010's	21 (19.27)	24.3611
2020's	28 (25.69)	2.80

Authors

Authors	Studies
Figiel, M; Kozlowska, U; Nichols, C; Wiatr, K	1
Machado, S; Novais, F; Rema, J; Sousa, TR	1
Jones, GM; Nock, MK	3
Erdmann, M; Hase, A; Hasler, G; Limbach, V	1
Johnson, MW	1
Basu, A; Belal, S; Jacob, T; Suleiman, M	1
Belouin, SJ; Berger, A; Coe, MA; Coker, AR; Comer, SD; Griffiths, RR; Heal, DJ; Hendricks, PS; Henningfield, JE; Nichols, CD; Sapienza, F; Vocci, FJ; Zia, FZ	1
Ebbesen Jensen, M; Fink-Jensen, A; Søgaard Juul, T	1
Bláhová, B; Chomynová, P; Kňažek, F; Kočárová, R; Mravčík, V; Plevková, M; Valeš, K	1
Ashworth, J; Heal, DJ; Henningfield, JE; Smith, SL	1
Carlyle, D; Crowe, M; Lacey, C; Manuel, J	1
Belouin, SJ; Heal, DJ; Henningfield, JE; Smith, SL	1
Ezeaka, UC; Kim, HJJ; Laprairie, RB	1
Amada, N; Jungaberle, H; Klein, M; Lea, T; Schecke, H	1
Chi, T; Gold, JA	1
Anderson, T; Dinh-Williams, LA; Hapke, E; Hui, K; Petranker, R; Rosenbaum, D; Weissman, C	1
Dunne, C; Ennis, P; Kavanagh, P; Kochelski, E; Mishraki-Berkowitz, T; O'Brien, J; Talbot, B; Wolf, UE	1
Abbott, KL; Boothe, DM; Dhanasekaran, M; Flannery, PC; Gill, KS; Pondugula, SR	1
Colunga, K; Dunn, RL; Etuk, A; Reinert, JP; Richardson, V	1
Mertens, LJ; Preller, KH	1
Bates, MLS; Trujillo, KA	1
Anderson, T; Barratt, MJ; Ferris, JA; Maier, LJ; Petranker, R; Winstock, AR	1
Hendricks, PS; Sexton, JD; Simonsson, O	1
Fradkin, D	1
Berghella, AP; Garcia-Romeu, A; Hendricks, PS; Johnson, MW; Regier, PS; Yaden, DB	1
Waters, K	1
Bayat, M	1
Carbonaro, TM; Griffiths, RR; Hurwitz, E; Johnson, MW	1
Griffiths, RR; Hendricks, PS; Henningfield, JE; Johnson, MW	1
Aixalà, M; Bouso, JC; Dos Santos, RG; Hallak, JEC	1
Alcázar-Córcoles, MÁ; Bouso, JC; Dos Santos, RG; Hallak, JEC	1
Andreassen, OA; Kvam, TM; Stewart, LH	1
Advenier, AS; Bévalot, F; Bottinelli, C; Cartiser, N; Fanton, L; Franchi, A; Honyiglo, E	1
Davis, AK; Erowid, E; Erowid, F; Garcia-Romeu, A; Griffiths, RR; Johnson, MW	1
Dolder, PC; Hutten, NRPW; Kuypers, KPC; Mason, NL	1
Bogenschutz, MP	2
Beck, O; Hägerkvist, R; Helander, A; Hultén, P	1
Adinoff, B; Burdick, BV	1
Borschmann, R; Kaar, S; Winstock, AR	1
Horáček, J; Páleníček, T; Tylš, F	1
de Veen, BT; Homberg, JR; Schellekens, AF; Verheij, MM	1
Johnson, MW; Nichols, CD; Nichols, DE	1
Hermle, L; Hewer, W; Kovar, KA; Ruchsow, M	1
Kovacic, P	1
Forman, RF; Lott, JP; Marlowe, DB	1
Griffin, C; Riley, S; Thompson, J	1
Opperhuizen, A; van Amsterdam, J; van den Brink, W	1
Ross, S	1
Dean, A; Hallock, RM; Knecht, ZA; Spencer, J; Taverna, EC	1
DORDEVIC, D; KANDIC, B	1
LEVINE, J; LUDWIG, AM	1
Emrich, HM; Passie, T; Schneider, U; Seifert, J	1
Cuddy, ML	1
Betz, C; Bickel, M; Ditting, T; Fichtlscherer, S; Gueller, S; Jacobi, V; Roesler, A; Stein, J; Watz, H; Weidauer, S	1
Fukiharu, T; Goda, Y; Kawahara, N; Makino, Y; Maruyama, T; Yokoyama, K	1
Lazauskas, R; Reingardiene, D; Vilcinskaite, J	1
Griffiths, RR; Jesse, R; McCann, U; Richards, WA	1
Hunt, N; McCambridge, J; Mitcheson, L; Winstock, A	1
Blackman, G; Riley, SC	1
Attema-de Jonge, ME; Franssen, EJ; Portier, CB	1
Cohen, S	1
Hutchison, S; Kesson, CM; Milroy, R; Young, RE	1
Peden, NR; Pringle, SD	1
Haan, J	1
Crooks, J; Peden, NR; Pringle, SD	1
Lassen, JF; Lassen, NF; Skov, J	2
Delgado, PL; Moreno, FA	1
Ebbehøj, NE; Fjeldberg, IA; Holm, JW	1
Karlson-Stiber, C; Westberg, U	1
Ghuran, A; Nolan, J	1
Beike, J; Madea, B; Musshoff, F	1
Gebhart, E	1
Lesinskas, D; Mills, PR; Watkinson, G	1
Glancy, G; Hall, D; Hyde, C; Omerod, P; Taylor, GS	1
Davies, NS	1
Logan, WJ	1
Brown, JK; Malone, MH	1
Haddad, LM	1
Grant, I; Mohns, L	1
Schwartz, RH; Smith, DE	1
Braden, NJ; Brown, RT	1
Leonard, HL; Rapoport, JL	1
Anglin, MD; Emboden, W; Fisher, DG; Thompson, JP	1
Kochansky, GE; Lieff, J; Salzman, C; Shader, RI	1
Brown, JK; Griffin, GD; Shapazian, L	1
Kugler, J	1
Lavenhar, MA; Sheffet, A	1
Unwin, JR	1
Kieffer, SN; Moritz, TB	1
Kieffer, SN; Mortiz, TB	1
Pahnke, WN	1
Herman, Z; Nowak, S	1
Leuner, H	1
Buckman, J	1
Mulkey, D	1
Peterson, GC; Wilson, MR	1
McCarthy, JP	1
Jorgensen, F	1
Seal, RE	1
Kaij, L	1
Cheek, FE; Joffe, M; Newell, S	1
Angst, J	1
Louria, DB	1

Reviews

38 review(s) available for psilocybin and Chemical Dependence

Article	Year
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders. Journal of neurochemistry, 2022, Volume: 162, Issue:1 Topics: Depressive Disorder, Major; Hallucinogens; Humans; Neurodegenerative Diseases; Neurology; Psilocybin; Psychiatry; Substance-Related Disorders	2022
Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation. Current topics in behavioral neurosciences, 2022, Volume: 56 Topics: Hallucinogens; Humans; Nicotiana; Psilocybin; Smoking Cessation; Substance-Related Disorders; Tobacco Use Disorder	2022
Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling. Neuropharmacology, 2022, 11-01, Volume: 218 Topics: Controlled Substances; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Substance-Related Disorders; United States	2022
Experiences of psilocybin treatment for clinical conditions: A qualitative meta-synthesis. International journal of mental health nursing, 2023, Volume: 32, Issue:4 Topics: Delivery of Health Care; Hallucinogens; Humans; Psilocybin; Smoking Cessation; Substance-Related Disorders	2023
Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models. Current topics in medicinal chemistry, 2023, Volume: 23, Issue:23 Topics: Anxiety; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Psilocybin; Substance-Related Disorders	2023
A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses. Journal of the neurological sciences, 2020, Apr-15, Volume: 411 Topics: Animals; Anxiety; Hallucinogens; Humans; Pharmaceutical Preparations; Psilocybin; Substance-Related Disorders	2020
Management of overdoses of salvia, kratom, and psilocybin mushrooms: a literature review. Expert review of clinical pharmacology, 2020, Volume: 13, Issue:8 Topics: Animals; Drug Overdose; Hallucinogens; Humans; Illicit Drugs; Mitragyna; Mushroom Poisoning; Psilocybin; Salvia; Substance-Related Disorders	2020
Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders. Pharmacopsychiatry, 2021, Volume: 54, Issue:4 Topics: Hallucinogens; Humans; Mood Disorders; Psilocybin; Psychiatry; Substance-Related Disorders	2021
Use and abuse of dissociative and psychedelic drugs in adolescence. Pharmacology, biochemistry, and behavior, 2021, Volume: 203 Topics: Adolescent; Adult; Age Factors; Animals; Dextromethorphan; Female; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Psilocybin; Risk-Taking; Substance-Related Disorders	2021
Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs. The International journal on drug policy, 2021, Volume: 98 Topics: Alcoholism; Hallucinogens; Humans; Psilocybin; Psychotherapy; Substance-Related Disorders	2021
[Classic psychedelic drugs and their potential therapeutic effect]. Ugeskrift for laeger, 2017, Sep-11, Volume: 179, Issue:37 Topics: Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Cluster Headache; Depression; Hallucinogens; Humans; Lysergic Acid Diethylamide; Obsessive-Compulsive Disorder; Psilocybin; Receptor, Serotonin, 5-HT2A; Substance-Related Disorders	2017
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act. Neuropharmacology, 2018, Volume: 142 Topics: Animals; Drug and Narcotic Control; Hallucinogens; Humans; Psilocybin; Substance-Related Disorders	2018
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert review of clinical pharmacology, 2018, Volume: 11, Issue:9 Topics: Anxiety Disorders; Banisteriopsis; Depressive Disorder; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Randomized Controlled Trials as Topic; Serotonin Agents; Substance-Related Disorders	2018
Psychedelic drugs in the treatment of anxiety, depression and addiction. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2018, 11-13, Volume: 138, Issue:18 Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Hallucinogens; Humans; Lysergic Acid Diethylamide; Obsessive-Compulsive Disorder; Psilocybin; Substance-Related Disorders	2018
Unpredictable Behavior Under the Influence of "Magic Mushrooms": A Case Report and Review of the Literature. Journal of forensic sciences, 2019, Volume: 64, Issue:4 Topics: Adolescent; Agaricales; Bile; Chromatography, Gas; Hallucinogens; Humans; Male; Psilocybin; Substance-Related Disorders; Suicide; Vitreous Body	2019
Cessation and reduction in alcohol consumption and misuse after psychedelic use. Journal of psychopharmacology (Oxford, England), 2019, Volume: 33, Issue:9 Topics: Adult; Alcohol Drinking; Cross-Sectional Studies; Ethanol; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mysticism; Psilocybin; Psychotropic Drugs; Retrospective Studies; Substance-Related Disorders; Surveys and Questionnaires	2019
Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin. Current drug abuse reviews, 2013, Volume: 6, Issue:1 Topics: Alcoholism; Animals; Brain; Clinical Trials as Topic; Combined Modality Therapy; Functional Neuroimaging; Hallucinogens; Humans; Psilocybin; Psychotherapy; Research Design; Substance-Related Disorders	2013
Psilocybin--summary of knowledge and new perspectives. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2014, Volume: 24, Issue:3 Topics: Animals; Behavior, Animal; Brain; Hallucinogens; Humans; Psilocybin; Substance-Related Disorders	2014
Psilocybin for treating substance use disorders? Expert review of neurotherapeutics, 2017, Volume: 17, Issue:2 Topics: Depression; Emotions; Hallucinogens; Humans; Psilocybin; Substance-Related Disorders	2017
Psychedelics as Medicines: An Emerging New Paradigm. Clinical pharmacology and therapeutics, 2017, Volume: 101, Issue:2 Topics: Anxiety; Brain; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Hallucinogens; Humans; Inflammation; Inflammation Mediators; Lysergic Acid Diethylamide; Mental Disorders; Mind-Body Therapies; Obsessive-Compulsive Disorder; Psilocybin; Psychotherapy; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Severity of Illness Index; Substance-Related Disorders	2017
[Hallucinogen-induced psychological disorders]. Fortschritte der Neurologie-Psychiatrie, 2008, Volume: 76, Issue:6 Topics: Adolescent; Adult; Hallucinogens; Humans; Lysergic Acid Diethylamide; N,N-Dimethyltryptamine; Psilocybin; Psychoses, Substance-Induced; Recurrence; Substance-Related Disorders	2008
Harm potential of magic mushroom use: a review. Regulatory toxicology and pharmacology : RTP, 2011, Volume: 59, Issue:3 Topics: Accidents; Agaricales; Animals; Hallucinogens; Humans; Netherlands; Panic Disorder; Psilocybin; Psychoses, Substance-Induced; Risk Assessment; Substance-Related Disorders	2011
The pharmacology of psilocybin. Addiction biology, 2002, Volume: 7, Issue:4 Topics: Agaricales; Animals; Brain; Controlled Clinical Trials as Topic; Hallucinogens; Humans; Mice; Psilocybin; Receptors, Presynaptic; Serotonin; Somatoform Disorders; Substance-Related Disorders	2002
Common drugs of abuse--Part II. The Journal of practical nursing, 2004,Spring, Volume: 54, Issue:1 Topics: 4-Butyrolactone; Catha; Designer Drugs; Dibenzothiazepines; Diterpenes; Diterpenes, Clerodane; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug and Narcotic Control; Flunitrazepam; Hallucinogens; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Methamphetamine; Motivation; N-Methyl-3,4-methylenedioxyamphetamine; Phencyclidine; Phenylpropanolamine; Piperazines; Psilocybin; Quetiapine Fumarate; Sodium Oxybate; Substance-Related Disorders; United States	2004
[Hallucinogenic mushrooms]. Medicina (Kaunas, Lithuania), 2005, Volume: 41, Issue:12 Topics: Adolescent; Adult; Agaricales; Animals; Brain; Electroencephalography; Guinea Pigs; Hallucinogens; History, 17th Century; History, 20th Century; History, 21st Century; Humans; Lethal Dose 50; Mice; Mushroom Poisoning; Psilocybin; Rats; Substance-Related Disorders; Time Factors	2005
[Drug dependence. A review of the narcotic and hallucinogenic effects of drugs]. Medizinische Monatsschrift fur Pharmazeuten, 1981, Volume: 4, Issue:5 Topics: Analgesics; Antitussive Agents; Cannabis; Cocaine; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Humans; Mescaline; Narcotics; Psilocybin; Substance-Related Disorders	1981
Recreational drug misuse: issues for the cardiologist. Heart (British Cardiac Society), 2000, Volume: 83, Issue:6 Topics: Adolescent; Adult; Amphetamines; Cannabis; Cardiovascular Diseases; Child; Cocaine; Drug Overdose; Female; Hallucinogens; Heroin; Humans; Lysergic Acid Diethylamide; Male; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Narcotics; Psilocybin; Substance-Related Disorders	2000
[The problem of mutagenic side effects of psychotropic substances. 2. Narcotics and addictive drugs]. Fortschritte der Medizin, 1979, Jan-18, Volume: 97, Issue:3 Topics: Dose-Response Relationship, Drug; Ethanol; Female; Humans; Infant, Newborn; Lysergic Acid Diethylamide; Male; Mescaline; Methadone; Morphine; Mutation; Narcotics; Psilocybin; Substance-Related Disorders	1979
Neurological aspects of hallucinogenic drugs. Advances in neurology, 1975, Volume: 13 Topics: Amphetamines; Animals; Brain; Brain Damage, Chronic; Cannabis; Catecholamines; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Haplorhini; Humans; Injections, Intravenous; Lysergic Acid Diethylamide; Mescaline; N,N-Dimethyltryptamine; Narcolepsy; Psilocybin; Rats; Seizures; Serotonin Antagonists; Substance-Related Disorders	1975
Chronic cerebral effects of alcohol and drug abuse. The International journal of the addictions, 1975, Volume: 10, Issue:5 Topics: Alcoholism; Amphetamines; Barbiturates; Brain Diseases; Cannabis; Cerebrovascular Disorders; Cocaine; Humans; Hypnotics and Sedatives; Lysergic Acid Diethylamide; Mescaline; Methylphenidate; Narcotics; Phenmetrazine; Psilocybin; Psychological Tests; Psychoses, Alcoholic; Substance-Related Disorders	1975
Hallucinogens. Pediatric clinics of North America, 1987, Volume: 34, Issue:2 Topics: Adolescent; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Phencyclidine; Psilocybin; Substance-Related Disorders	1987
Illicit drug use among Canadian youth. I. Canadian Medical Association journal, 1968, Feb-24, Volume: 98, Issue:8 Topics: Adolescent; Adult; Amphetamine; Canada; Cannabis; Education; Hallucinogens; Humans; Mescaline; Psilocybin; Social Class; Solvents; Substance-Related Disorders	1968
Psychedelic drugs. Pennsylvania medicine, 1968, Volume: 71, Issue:4 Topics: Adolescent; Adult; Cannabis; Drug and Narcotic Control; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Middle Aged; Psilocybin; Substance-Related Disorders	1968
Psychedelic drugs. Pennsylvania medicine, 1968, Volume: 71, Issue:4 Topics: Adolescent; Adult; Cannabis; Drug and Narcotic Control; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mescaline; Middle Aged; Psilocybin; Substance-Related Disorders	1968
Psychedelic drugs and mystical experience. International psychiatry clinics, 1969, Volume: 5, Issue:4 Topics: Cognition; Dextroamphetamine; Esthetics; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mysticism; Psilocybin; Religion; Substance-Related Disorders; Unconscious, Psychology	1969
[The abuse of psychodelics: a social and medical problem]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1970, May-11, Volume: 25, Issue:19 Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Social Problems; Substance-Related Disorders	1970
[Narcotics abuse in adolescents]. Der Nervenarzt, 1971, Volume: 42, Issue:6 Topics: Adolescent; Age Factors; Cannabis; Conflict, Psychological; Family Characteristics; Forensic Medicine; Germany, West; Hallucinogens; Health Education; Humans; Lysergic Acid Diethylamide; Mescaline; Motivation; Narcotics; Opium; Psilocybin; Psychopharmacology; Substance-Related Disorders	1971
Social and medical aspects of illicit use of LSD. The International journal of social psychiatry, 1971,Summer, Volume: 17, Issue:3 Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Animals; Commerce; Female; Humans; Jurisprudence; Lysergic Acid Diethylamide; Male; Maternal-Fetal Exchange; Pregnancy; Psilocybin; Religion; Sex Chromosome Aberrations; Social Class; Social Conformity; Social Control, Formal; Students; Substance-Related Disorders; Suicide; Unemployment; United States	1971

Trials

2 trial(s) available for psilocybin and Chemical Dependence

Article	Year
A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. Drug and alcohol dependence, 2013, Jun-01, Volume: 130, Issue:1-3 Topics: Adolescent; Adult; Agaricales; Female; Hallucinogens; Humans; Illicit Drugs; Male; Perception; Psilocybin; Students; Substance-Related Disorders; Universities; Young Adult	2013
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 2006, Volume: 187, Issue:3 Topics: Adult; Affect; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Hallucinogens; Heart Rate; Humans; Lysergic Acid Diethylamide; Male; Psilocybin; Spirituality; Substance-Related Disorders; Surveys and Questionnaires	2006

Article

Year

A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.

Drug and alcohol dependence, 2013, Jun-01, Volume: 130, Issue:1-3

Topics: Adolescent; Adult; Agaricales; Female; Hallucinogens; Humans; Illicit Drugs; Male; Perception; Psilocybin; Students; Substance-Related Disorders; Universities; Young Adult

2013

Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.

Psychopharmacology, 2006, Volume: 187, Issue:3

Topics: Adult; Affect; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Hallucinogens; Heart Rate; Humans; Lysergic Acid Diethylamide; Male; Psilocybin; Spirituality; Substance-Related Disorders; Surveys and Questionnaires

2006

Other Studies

69 other study(ies) available for psilocybin and Chemical Dependence

Article	Year
Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets. Current topics in medicinal chemistry, 2022, Volume: 22, Issue:15 Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Psychiatry; Substance-Related Disorders	2022
MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults. Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:1 Topics: Adolescent; Adult; Aged; Female; Hallucinogens; Health Surveys; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Stress, Psychological; Substance-Related Disorders; Suicidal Ideation; United States; Young Adult	2022
Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes. Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:1 Topics: Adolescent; Adult; Aged; Depressive Disorder, Major; Female; Hallucinogens; Health Surveys; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Patient Acuity; Psilocybin; Substance-Related Disorders; United States; Young Adult	2022
Analysis of recreational psychedelic substance use experiences classified by substance. Psychopharmacology, 2022, Volume: 239, Issue:2 Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Substance-Related Disorders	2022
Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension. Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:1 Topics: Adolescent; Adult; Aged; Crime; Criminal Behavior; Female; Hallucinogens; Health Surveys; Humans; Male; Middle Aged; Psilocybin; Substance-Related Disorders; United States; Young Adult	2022
From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder. The Journal of nervous and mental disease, 2022, 08-01, Volume: 210, Issue:8 Topics: Agaricales; Humans; Psilocybin; Psychotic Disorders; Rhabdomyolysis; Substance-Related Disorders	2022
The use of classic psychedelics among adults: a Danish online survey study. Nordic journal of psychiatry, 2023, Volume: 77, Issue:4 Topics: Adult; Denmark; Ethanol; Female; Hallucinogens; Humans; Male; N,N-Dimethyltryptamine; Psilocybin; Substance-Related Disorders; Surveys and Questionnaires	2023
Use of psychedelics in the Czech Republic: results of recent population surveys. Central European journal of public health, 2022, Volume: 30, Issue:3 Topics: Adult; Cannabis; Cross-Sectional Studies; Czech Republic; Hallucinogens; Humans; Illicit Drugs; Ketamine; Lysergic Acid Diethylamide; Male; Psilocybin; Substance-Related Disorders	2022
Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective. Journal of psychopharmacology (Oxford, England), 2023, Volume: 37, Issue:1 Topics: Animals; Controlled Substances; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Substance-Related Disorders; United States	2023
Psychedelics: Threshold of a Therapeutic Revolution. Neuropharmacology, 2023, Sep-15, Volume: 236 Topics: Anxiety; Depressive Disorder, Major; Hallucinogens; Humans; Psilocybin; Substance-Related Disorders	2023
Microdosing psychedelics: Motivations, subjective effects and harm reduction. The International journal on drug policy, 2020, Volume: 75 Topics: Adult; Anxiety; Depression; Dose-Response Relationship, Drug; Female; Hallucinogens; Harm Reduction; Humans; Lysergic Acid Diethylamide; Male; Mental Health; Middle Aged; Motivation; Psilocybin; Substance-Related Disorders; Surveys and Questionnaires; Young Adult	2020
Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities. Journal of psychopharmacology (Oxford, England), 2020, Volume: 34, Issue:6 Topics: Adolescent; Adult; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mental Disorders; Psilocybin; Substance-Related Disorders; Surveys and Questionnaires; Young Adult	2020
The Psilocin (4-hydroxy-N,N-dimethyltryptamine) and Bufotenine (5-hydroxy-N,N-dimethyltryptamine) Case: Ensuring the Correct Isomer has Been Identified. Journal of forensic sciences, 2020, Volume: 65, Issue:5 Topics: Bufotenin; Chromatography, Thin Layer; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Isomerism; Psilocybe; Psilocybin; Spectroscopy, Fourier Transform Infrared; Substance-Related Disorders	2020
Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances. ACS chemical neuroscience, 2020, 05-20, Volume: 11, Issue:10 Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Substance-Related Disorders	2020
Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention. Journal of psychopharmacology (Oxford, England), 2022, Volume: 36, Issue:1 Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Female; Hallucinogens; Humans; Intention; Lysergic Acid Diethylamide; Male; Psilocybin; Substance-Related Disorders; Surveys and Questionnaires; Young Adult	2022
Associations between lifetime classic psychedelic use and markers of physical health. Journal of psychopharmacology (Oxford, England), 2021, Volume: 35, Issue:4 Topics: Adult; Body Mass Index; Drug Users; Female; Hallucinogens; Health Status; Heart Diseases; Humans; Lysergic Acid Diethylamide; Male; Mental Health; Neoplasms; Psilocybin; Self Report; Substance-Related Disorders; Surveys and Questionnaires; United States	2021
Psilocybin: A brief overview for psychiatric mental health nurse practitioners. Perspectives in psychiatric care, 2022, Volume: 58, Issue:3 Topics: Hallucinogens; Humans; Mental Health; Nurse Practitioners; Psilocybin; Substance-Related Disorders	2022
Pharmacologic Similarities and Differences Among Hallucinogens. Journal of clinical pharmacology, 2021, Volume: 61 Suppl 2 Topics: Biogenic Monoamines; Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid; Substance-Related Disorders; Tryptamines	2021
Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences. Psychopharmacology, 2018, Volume: 235, Issue:2 Topics: Adult; Blood Pressure; Dextromethorphan; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hallucinations; Hallucinogens; Heart Rate; Humans; Male; Music; Mysticism; Psilocybin; Substance-Related Disorders; Surveys and Questionnaires; Young Adult	2018
Psychedelics and Personality. ACS chemical neuroscience, 2018, 10-17, Volume: 9, Issue:10 Topics: Anxiety Disorders; Banisteriopsis; Clinical Trials as Topic; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mood Disorders; N,N-Dimethyltryptamine; Personality; Plant Preparations; Psilocybin; Receptor, Serotonin, 5-HT2A; Substance-Related Disorders	2018
Motives and Side-Effects of Microdosing With Psychedelics Among Users. The international journal of neuropsychopharmacology, 2019, 07-01, Volume: 22, Issue:7 Topics: Adult; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Motivation; Performance-Enhancing Substances; Psilocybin; Substance-Related Disorders; Surveys and Questionnaires	2019
Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project. Scandinavian journal of clinical and laboratory investigation, 2013, Volume: 73, Issue:5 Topics: Adolescent; Adult; Amphetamines; Benzodiazepines; Cannabinoid Receptor Agonists; Female; Humans; Illicit Drugs; Indoles; Male; Methamphetamine; Middle Aged; Psilocybin; Psychotropic Drugs; Secologanin Tryptamine Alkaloids; Substance-Related Disorders; Sweden; Tryptamines; Young Adult	2013
A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment. The American journal of drug and alcohol abuse, 2013, Volume: 39, Issue:5 Topics: Hallucinogens; Humans; Hyperventilation; Opioid-Related Disorders; Psilocybin; Randomized Controlled Trials as Topic; Research Design; Substance-Related Disorders	2013
Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:1 Topics: Adult; Australia; Behavior, Addictive; Drug Users; Europe; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Male; N,N-Dimethyltryptamine; Prevalence; Psilocybin; Substance-Related Disorders; United Kingdom; United States; Young Adult	2014
It's time to take psilocybin seriously as a possible treatment for substance use disorders. The American journal of drug and alcohol abuse, 2017, Volume: 43, Issue:1 Topics: Follow-Up Studies; Humans; Psilocybin; Smoking Cessation; Substance-Related Disorders	2017
Unifying electron transfer mechanism for psilocybin and psilocin. Medical hypotheses, 2009, Volume: 73, Issue:4 Topics: Electrochemistry; Electron Transport; Humans; Illicit Drugs; Models, Biological; Models, Chemical; Oxidation-Reduction; Oxidative Stress; Psilocybin; Reactive Oxygen Species; Substance-Related Disorders	2009
Availability of websites offering to sell psilocybin spores and psilocybin. Journal of psychoactive drugs, 2009, Volume: 41, Issue:3 Topics: Hallucinogens; Humans; Internet; Psilocybe; Psilocybin; Spores, Fungal; Substance-Related Disorders	2009
Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds. The International journal on drug policy, 2010, Volume: 21, Issue:6 Topics: Adolescent; Adult; Female; Focus Groups; Hallucinogens; Humans; Male; Philosophy; Politics; Psilocybe; Psilocybin; Spirituality; Substance-Related Disorders; United Kingdom; Young Adult	2010
Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies. The Psychiatric clinics of North America, 2012, Volume: 35, Issue:2 Topics: Adult; Animals; Behavior, Addictive; Clinical Trials as Topic; Cognition; Dopamine; Dopamine Agonists; Glutamates; Hallucinogens; Humans; Ibogaine; Lysergic Acid; Neuronal Plasticity; Nucleus Accumbens; Phytotherapy; Prefrontal Cortex; Psilocybin; Religion; Reward; Serotonin 5-HT2 Receptor Agonists; Substance Withdrawal Syndrome; Substance-Related Disorders	2012
[COMPARISON OF PSYCHOPHARMACA LSD-25, BOL-148 AND PSILOCYBIN IN CLINICAL PRACTICE]. Vojnosanitetski pregled, 1963, Volume: 20 Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Substance-Related Disorders	1963
PATTERNS OF HALLUCINOGENIC DRUG ABUSE. JAMA, 1965, Jan-11, Volume: 191 Topics: Amphetamine; Amphetamines; Barbiturates; Cannabis; Drug and Narcotic Control; Hallucinogens; Humans; Indoles; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Psychoses, Substance-Induced; Psychotic Disorders; Sexual Behavior; Substance-Related Disorders; Toxicology	1965
Severe rhabdomyolysis, acute renal failure and posterior encephalopathy after 'magic mushroom' abuse. European journal of emergency medicine : official journal of the European Society for Emergency Medicine, 2005, Volume: 12, Issue:6 Topics: Acute Kidney Injury; Adult; Central Nervous System Diseases; Hallucinogens; Humans; Male; Mushroom Poisoning; Psilocybin; Rhabdomyolysis; Substance-Related Disorders	2005
Phylogenetic relationship of psychoactive fungi based on rRNA gene for a large subunit and their identification using the TaqMan assay (II). Forensic science international, 2006, Nov-10, Volume: 163, Issue:1-2 Topics: Agaricales; Base Sequence; DNA, Fungal; Drug and Narcotic Control; Gas Chromatography-Mass Spectrometry; Genes, rRNA; Hallucinogens; Humans; Japan; Molecular Sequence Data; Phylogeny; Polymerase Chain Reaction; Psilocybin; RNA, Fungal; Substance Abuse Detection; Substance-Related Disorders	2006
5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. European addiction research, 2007, Volume: 13, Issue:1 Topics: Adult; Cross-Sectional Studies; Female; Hallucinogens; Humans; Incidence; Ketamine; Lysergic Acid Diethylamide; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prevalence; Psilocybin; Substance-Related Disorders; United Kingdom	2007
Between prohibitions: patterns and meanings of magic mushroom use in the UK. Substance use & misuse, 2008, Volume: 43, Issue:1 Topics: Adolescent; Adult; Agaricales; Data Collection; Female; Focus Groups; Hallucinogens; Humans; Illicit Drugs; Male; Middle Aged; Psilocybin; Substance-Related Disorders; Surveys and Questionnaires; United Kingdom	2008
[Automutilation after consumption of hallucinogenic mushrooms]. Nederlands tijdschrift voor geneeskunde, 2007, Dec-29, Volume: 151, Issue:52 Topics: Adult; Agaricales; Hallucinogens; Humans; Male; Mushroom Poisoning; Psilocybin; Self Mutilation; Substance-Related Disorders	2007
Dependence on LSD and other hallucinogenic drugs. JAMA, 1967, Oct-02, Volume: 202, Issue:1 Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Psychoses, Substance-Induced; Substance-Related Disorders; United States; United States Food and Drug Administration	1967
The hallucinogens and the inhalants. The Psychiatric clinics of North America, 1984, Volume: 7, Issue:4 Topics: 3,4-Methylenedioxyamphetamine; Adolescent; DOM 2,5-Dimethoxy-4-Methylamphetamine; Dronabinol; Hallucinogens; Humans; Ketamine; Lysergic Acid Diethylamide; Mescaline; N,N-Dimethyltryptamine; Phencyclidine; Psilocybin; Solvents; Substance-Related Disorders	1984
The rising price of mushrooms. Lancet (London, England), 1982, Jan-23, Volume: 1, Issue:8265 Topics: Adolescent; Adult; Basidiomycota; Child; Costs and Cost Analysis; Female; Hallucinogens; Humans; Male; Psilocybin; Scotland; Substance-Related Disorders	1982
Hallucinogenic fungi. Lancet (London, England), 1982, Feb-13, Volume: 1, Issue:8268 Topics: Adolescent; Basidiomycota; Female; Humans; Male; Psilocybin; Scotland; Substance-Related Disorders	1982
The problem of psilocybin mushroom abuse. Human toxicology, 1982, Volume: 1, Issue:4 Topics: Adolescent; Adult; Behavior; Child; Female; Humans; Male; Mushroom Poisoning; Perceptual Disorders; Psilocybin; Substance-Related Disorders	1982
[Hallucinogenic psilocybine-containing mushrooms. Patterns of use among Danish abusers]. Ugeskrift for laeger, 1993, May-03, Volume: 155, Issue:18 Topics: Adolescent; Adult; Basidiomycota; Cross-Sectional Studies; Denmark; Female; Humans; Male; Psilocybin; Substance-Related Disorders; Surveys and Questionnaires	1993
Hallucinogen-induced relief of obsessions and compulsions. The American journal of psychiatry, 1997, Volume: 154, Issue:7 Topics: Adult; Humans; Male; Mescaline; Obsessive-Compulsive Disorder; Psilocybin; Self Medication; Substance-Related Disorders	1997
[Hallucinogenic mushrooms in Denmark]. Ugeskrift for laeger, 1997, Aug-18, Volume: 159, Issue:34 Topics: Basidiomycota; Denmark; Hallucinogens; Humans; Psilocybin; Substance-Related Disorders	1997
[Hallucinogenic mushrooms popular again--sale via Internet]. Lakartidningen, 1999, Feb-17, Volume: 96, Issue:7 Topics: Adolescent; Adult; Drug Information Services; Hallucinogens; Humans; Internet; Male; Mushroom Poisoning; Psilocybin; Substance-Related Disorders	1999
Hallucinogenic mushrooms on the German market - simple instructions for examination and identification. Forensic science international, 2000, Sep-11, Volume: 113, Issue:1-3 Topics: Agaricales; Chromatography, Liquid; Drug and Narcotic Control; Germany; Hallucinogens; Humans; Psilocybin; Substance Abuse Detection; Substance-Related Disorders; Toxicology	2000
The danger of hallucinogenic mushrooms. Scottish medical journal, 1979, Volume: 24, Issue:4 Topics: Adolescent; Adult; Humans; Male; Mushroom Poisoning; Psilocybin; Substance-Related Disorders	1979
Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications. The British journal of psychiatry : the journal of mental science, 1978, Volume: 132 Topics: Adult; Basidiomycota; Hallucinations; Humans; Male; Mental Disorders; Psilocybin; Substance-Related Disorders	1978
Psychiatric symptoms and hallucinogenic compounds. British medical journal, 1979, Sep-29, Volume: 2, Issue:6193 Topics: Adult; Basidiomycota; Humans; Male; Psilocybin; Psychoses, Substance-Induced; Substance-Related Disorders	1979
Status of drug quality in the street-drug market--an update. Clinical toxicology, 1976, Volume: 9, Issue:2 Topics: Amphetamine; Amphetamines; Cannabis; Cocaine; Dronabinol; Heroin; Humans; Lysergic Acid Diethylamide; Mescaline; Opium; Pharmaceutical Preparations; Psilocybin; Substance-Related Disorders	1976
Management of hallucinogen abuse. American family physician, 1976, Volume: 14, Issue:1 Topics: Adolescent; Adult; Amphetamines; Basidiomycota; Cannabis; Child; Condiments; Diazepam; Fruit; Hallucinogens; Humans; Hyperkinesis; Lysergic Acid Diethylamide; Mescaline; N,N-Dimethyltryptamine; Phencyclidine; Plants; Psilocybin; Substance-Related Disorders	1976
[Consumption of psilocybin-containing hallucinogenic mushrooms by young people]. Ugeskrift for laeger, 1992, Sep-21, Volume: 154, Issue:39 Topics: Adolescent; Adult; Basidiomycota; Denmark; Hallucinogens; Humans; Psilocybin; Substance-Related Disorders; Surveys and Questionnaires	1992
Hallucinogenic mushrooms. Clinical pediatrics, 1988, Volume: 27, Issue:2 Topics: Adolescent; Female; Humans; Lysergic Acid Diethylamide; Male; Mushroom Poisoning; Psilocybin; Substance-Related Disorders	1988
Relief of obsessive-compulsive symptoms by LSD and psilocin. The American journal of psychiatry, 1987, Volume: 144, Issue:9 Topics: Adolescent; Humans; Lysergic Acid Diethylamide; Male; Obsessive-Compulsive Disorder; Psilocybin; Serotonin; Substance-Related Disorders	1987
Mushroom use by college students. Journal of drug education, 1985, Volume: 15, Issue:2 Topics: Adolescent; Adult; California; Female; Humans; Illicit Drugs; Male; Psilocybin; Students; Substance-Related Disorders; Universities	1985
The psychology of hallucinogenic drug discontinuers. The American journal of psychiatry, 1972, Volume: 129, Issue:6 Topics: Adult; Anxiety; Depression; Female; Gambling; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mental Disorders; Mescaline; MMPI; Personality; Psilocybin; Psychological Tests; Substance-Related Disorders	1972
A rapid screening procedure for some "street drugs" by thin-layer chromatography. Journal of chromatography, 1972, Jan-19, Volume: 64, Issue:1 Topics: Aldehydes; Amphetamine; Chromatography, Thin Layer; Hallucinogens; Humans; Indicators and Reagents; Lysergic Acid Diethylamide; Mescaline; Methods; p-Dimethylaminoazobenzene; Phencyclidine; Platinum; Psilocybin; Solvents; Strychnine; Substance-Related Disorders	1972
[Electroencephalography in drug addicts]. Deutsche medizinische Wochenschrift (1946), 1973, May-18, Volume: 98, Issue:20 Topics: Cannabis; Electroencephalography; Humans; Lysergic Acid Diethylamide; Mescaline; Morphine Dependence; Psilocybin; Substance-Related Disorders	1973
Recent trends in nonmedical use of drugs reported by students in two suburban New Jersey communities. Preventive medicine, 1973, Volume: 2, Issue:4 Topics: Adolescent; Age Factors; Cannabis; Cocaine; Female; Follow-Up Studies; Heroin Dependence; Humans; Hypnotics and Sedatives; Lysergic Acid Diethylamide; Male; Mescaline; Methamphetamine; New Jersey; Nonprescription Drugs; Peer Group; Psilocybin; Sex Factors; Smoking; Students; Substance-Related Disorders; Surveys and Questionnaires	1973
Psilocybin. Texas medicine, 1972, Volume: 68, Issue:7 Topics: Chemical Phenomena; Chemistry; Humans; Psilocybin; Substance-Related Disorders	1972
A perspective on drug abuse. Mayo Clinic proceedings, 1971, Volume: 46, Issue:7 Topics: Affective Symptoms; Alcoholic Beverages; Amphetamine; Barbiturates; Cannabis; Drug and Narcotic Control; Heroin; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Substance-Related Disorders; Tranquilizing Agents; United States	1971
Some less familiar drugs of abuse. The Medical journal of Australia, 1971, Nov-20, Volume: 2, Issue:21 Topics: Amyl Nitrite; Australia; Basidiomycota; Diphenhydramine; Fruit; Humans; Mescaline; Methaqualone; New Zealand; Parasympatholytics; Petroleum; Phenethylamines; Psilocybin; Substance-Related Disorders	1971
Abuse of psychotomimetics. Acta psychiatrica Scandinavica. Supplementum, 1968, Volume: 203 Topics: Adolescent; Adult; Cannabis; Crime; Denmark; Educational Status; Family; Family Characteristics; Female; Hallucinogens; Humans; Lysergic Acid Diethylamide; Male; Mental Disorders; Occupations; Psilocybin; Sex Factors; Social Class; Social Problems; Substance-Related Disorders	1968
The current status of the hallucinogenic drugs. The Australian and New Zealand journal of psychiatry, 1970, Volume: 4, Issue:2 Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Psilocybin; Substance-Related Disorders	1970
[Habit forming drugs. 2. Hallucinogens]. Lakartidningen, 1969, Nov-26, Volume: 66, Issue:48 Topics: Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Psychoses, Substance-Induced; Substance-Related Disorders; Suicide	1969
Deceptions in the illicit drug market. Science (New York, N.Y.), 1970, Feb-27, Volume: 167, Issue:3922 Topics: Benzopyrans; Cannabis; Chemistry, Pharmaceutical; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Substance-Related Disorders; Tablets; United States	1970
[Hallucinogen abuse]. Schweizerische medizinische Wochenschrift, 1970, Apr-18, Volume: 100, Issue:16 Topics: Adolescent; Adult; Affective Symptoms; Cannabis; Drug and Narcotic Control; Hallucinogens; Humans; Juvenile Delinquency; Mescaline; Perceptual Disorders; Psilocybin; Social Control, Formal; Social Control, Informal; Substance-Related Disorders; Suicide; Switzerland	1970
The hallucinogenic drugs--their use and abuse. The Medical journal of Australia, 1968, Jan-27, Volume: 1, Issue:4 Topics: Australia; Hallucinogens; Humans; Lysergic Acid Diethylamide; New Zealand; Psilocybin; Substance-Related Disorders	1968
Some aspects of the current drug scene with emphasis on drugs in use by adolescents. Pediatrics, 1968, Volume: 42, Issue:6 Topics: Adolescent; Amphetamine; Aphrodisiacs; Cannabis; Condiments; Hallucinogens; Health Education; Heroin; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Substance-Related Disorders; United States	1968